CONTROL (N = 1,896) . | NOFS (N = 102) . | P Value . | |
---|---|---|---|
Tumor volume (ccm) | 1.35 (± 1.88) | 1.57 (± 1.72) | 0.228 |
Conformity index (Paddick) | 0.76 (± 0.12) | 0.80 (± 0.26) | 0.127 |
Therapeutical dose (Gy) | 12.81 (± 0.45) | 12.85 (± 0.36) | 0.256 |
Isodose (%) | 62.16 (± 5.28) | 62.17 (± 5.36) | 0.987 |
Maximal dose (Gy) | 20.75 (± 1.72) | 20.81 (± 1.77) | 0.721 |
Mean dose (Gy) | 16.35 (± 0.92) | 17.06 (± 4.86) | 0.242 |
CONTROL (N = 1,896) . | NOFS (N = 102) . | P Value . | |
---|---|---|---|
Tumor volume (ccm) | 1.35 (± 1.88) | 1.57 (± 1.72) | 0.228 |
Conformity index (Paddick) | 0.76 (± 0.12) | 0.80 (± 0.26) | 0.127 |
Therapeutical dose (Gy) | 12.81 (± 0.45) | 12.85 (± 0.36) | 0.256 |
Isodose (%) | 62.16 (± 5.28) | 62.17 (± 5.36) | 0.987 |
Maximal dose (Gy) | 20.75 (± 1.72) | 20.81 (± 1.77) | 0.721 |
Mean dose (Gy) | 16.35 (± 0.92) | 17.06 (± 4.86) | 0.242 |
CONTROL (N = 1,896) . | NOFS (N = 102) . | P Value . | |
---|---|---|---|
Tumor volume (ccm) | 1.35 (± 1.88) | 1.57 (± 1.72) | 0.228 |
Conformity index (Paddick) | 0.76 (± 0.12) | 0.80 (± 0.26) | 0.127 |
Therapeutical dose (Gy) | 12.81 (± 0.45) | 12.85 (± 0.36) | 0.256 |
Isodose (%) | 62.16 (± 5.28) | 62.17 (± 5.36) | 0.987 |
Maximal dose (Gy) | 20.75 (± 1.72) | 20.81 (± 1.77) | 0.721 |
Mean dose (Gy) | 16.35 (± 0.92) | 17.06 (± 4.86) | 0.242 |
CONTROL (N = 1,896) . | NOFS (N = 102) . | P Value . | |
---|---|---|---|
Tumor volume (ccm) | 1.35 (± 1.88) | 1.57 (± 1.72) | 0.228 |
Conformity index (Paddick) | 0.76 (± 0.12) | 0.80 (± 0.26) | 0.127 |
Therapeutical dose (Gy) | 12.81 (± 0.45) | 12.85 (± 0.36) | 0.256 |
Isodose (%) | 62.16 (± 5.28) | 62.17 (± 5.36) | 0.987 |
Maximal dose (Gy) | 20.75 (± 1.72) | 20.81 (± 1.77) | 0.721 |
Mean dose (Gy) | 16.35 (± 0.92) | 17.06 (± 4.86) | 0.242 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.